Outcome of Board Meeting Dated May 21, 2026

Revenue growth above 20%Profit growth above 25%Related-party transactionsResults View source PDF Explain this filing

NGLFINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+10.9%Reaction day

₹2525.00

prior close

₹2569.80

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+10.8% vs market

Pharmaceuticals peers, median of 164sector-0.1%+11.0% vs sector

On the reaction day the stock moved 10.8 pts more than Nifty Microcap 250 and 11.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.4

10m

-5.8

15m

-10.2

30m

-9.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+10.9+0.1+10.8-0.1+11.0

Next day

+12.7+1.7+11.0+0.9+11.8

+10.9+2.4+8.5+0.9+10.1

+4.4+2.4+2.0+0.7+3.7

+10.9+1.7+9.2+0.8+10.1

+9.2+0.6+8.6+0.0+9.2

+5.0+1.9+3.0-0.1+5.0

15d

+24.8+4.9+19.9+1.0+23.7

+24.2+8.9+15.2+3.0+21.2

+29.0+7.5+21.5+4.4+24.6

+13.9+13.6+0.3+7.9+6.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NGL Fine Chem's Board approved audited FY26 results showing strong performance. Consolidated revenue grew 36% to Rs. 50,095.47 lakhs from Rs. 36,825.67 lakhs. Profit after tax more than doubled to Rs. 4,812.67 lakhs from Rs. 2,112.43 lakhs, representing 128% growth. EPS improved to Rs. 77.90 from Rs. 34.19. The Board recommended a final dividend of Rs. 1.75 per share (Rs. 108.12 lakhs total). Key appointments include reappointment of Mr. Rajesh Lawande as Whole-Time Director and Mrs. Sarala Menon as Independent Director, both for 5-year terms subject to shareholder approval. The 45th AGM is scheduled for August 25, 2026.

Likely market impact

Strong financial results with over 100% PAT growth and healthy dividend declaration are positive signals for shareholders. The company shows robust revenue growth and profitability improvement. No audit qualifications indicate clean financials.